H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street rises on revived AI momentum as earnings season picks up
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: NMRA) | Delayed: 0.38 -0.01 (2.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.39 | 52 Week High | $ | |||
| Open | $0.39 | 52 Week Low | $ | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.38 | EPS | $ | |||
| Volume | 930,965 | |||||
